Antinociceptive effects of opioids following acute and chronic administration of butorphanol: Influence of stimulus intensity and relative efficacy at the mu receptor

Psychopharmacology

Volumn 143, Issue 3, 1999, Pages 261-269

  Smith, Mark A ^a   Barrett, Andrew C ^a   Picker, Mitchell J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antinociception; Butorphanol; Opioid; Rat; Relative efficacy; Stimulus intensity; Tolerance

Indexed keywords

BUTORPHANOL; DEZOCINE; ETORPHINE; LEVORPHANOL; MORPHINE; MU OPIATE RECEPTOR; NALBUPHINE; OPIATE AGONIST; PENTAZOCINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NEUROMODULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANIMALS; BUTORPHANOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; MALE; NARCOTIC ANTAGONISTS; PAIN; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, MU; TEMPERATURE;

EID: 0032956076     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050945     Document Type: Article

References (48)

1. Adams JU, Paronis CA, Holtzman SG (1990) Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 255:1027-1032
2. Appanaitis HA, Allen RM, Walker EA, Dykstra LA (1998) Naltrexone-derived pA2 analysis of the antinociceptive effects of opioids in rats. NIDA Res Monogr 178:224
3. Appelbaum BD, Holtzman SG (1985) Restraint stress enhances morphine-induced analgesia in the rat without changing apparent affinity of receptor. Life Sci 36:1069-1074
4. Bailey AG, Valley RD, Freid EB, Calhoun P (1995) Epidural morphine combined with epidural or intravenous butorphanol for postoperative analgesia in pediatric patients. Anesth Analg 79: 340-344
5. 2 response and ventilation after fentanyl anesthesia. Anesth Analg 66:517-522
6. Butelman ER, Winger G, Zernig G, Woods JH (1995) Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. J Pharmacol Exp Ther 272:845-843
7. Calcagnetti DJ, Holtzman SG (1990) Factors affecting restraint stress-induced potentiation of morphine analgesia. Brain Res 537:157-162
8. Craft RM, Dykstra LA (1990) Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule. J Pharmacol Exp Ther 252:945-952
9. Craft RM, Henley ST, Haaseth RC, Hruby VJ, Porreca F (1995) Opioid antinociception in a rat model of visceral pain: systemic verses local drug administration. J Pharmacol Exp Ther 275:1535-1542
10. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245-252
11. France CP, Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J Pharmacol Exp Ther 254:626-632
12. Garner HR, Burke TF, Lawhorn CD, Stoner JM, Wessinger WD (1997) Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement. J Pharmacol Exp Ther 282:1253-1261
13. Horan P, Ho IK (1989a) Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol Biochem Behav 34:847-854
14. Horan P, Ho IK (1989b) Butorphanol precipitates abstinence in morphine dependent rats. Eur J Pharmacol 170:265-268
15. Howell LL, Bergman J, Morse WH (1988) Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther 245:364-372
16. Howes JF (1981) A simple, reliable method for predicting the physical dependence liability of narcotic antagonist analgesics in the rat. Pharmacol Biochem Behav 14:689-692
17. Hughes CE, Dykstra LA, Picker MJ (1996) Behavioral tolerance and cross-tolerance to the response rate-decreasing effects of mu opioids in rats. Behav Pharmacol 7:228-236
18. Lawhorn CD, McNitt JD, Fibuch EE, Joyce JT, Leadley RJ (1991) Epidural morphine with butorphanol for postoperative analgesia after cesarean delivery. Anesth Analg 72:53-57
19. Mickelson MM, Lahti RA (1985) Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea big brain. Res Commun Chem Pathol Pharmacol 47:255-263
20. Morgan D, Picker MJ (1996) Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor. Behav Pharmacol 6: 261-275
21. Morgan D, Picker MJ (1998) The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu receptor. Psychopharmacology 140:20-28
22. Morgan D, Cook CD, Smith MA, Picker MJ (1999) Examination of the interactions between various mu opioids and morphine in the rat tail-withdrawal procedure: role of intrinsic efficacy and stimulus intensity. Anesth Analg (in press)
23. Neil A (1982) Morphine-and methadone-tolerant mice differ in cross-tolerance to other opiates. Naunyn-Schmiedeberg's Arch Pharmacol 320:50-53
24. O'Neill SJ, Collins MA, Pettit HO, McNutt RW, Chang KJ (1997) Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice. J Pharmacol Exp Ther 282:271-277
25. Paronis CA, Holtzman SG (1992) Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J Pharmacol Exp Ther 262:1-9
26. Paronis CA, Holtzman SG (1994) Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psychopharmacology 114:601-610
27. Picker MJ (1997) Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists. J Pharmacol Exp Ther 283:1-9
28. Picker MJ, Negus SS, Craft RM (1990) Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure. Pharmacol Biochem Behav 36:563-568
29. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D, Dykstra LA (1993) Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and inter-animal differences. J Pharmacol Exp Ther 266:756-767
30. Pitts RC, West JP, Hapke DM, Morgan D, Dykstra LA, Picker MJ (1996) Opioids and rate of positively reinforced behavior: II. Antagonism by beta-funaltrexamine. Exp Clin Psychopharmacol 4:389-395
31. Portenoy RK, Foley KM (1986) Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 25:171-186
32. Portnoy LG, Hustead DR (1992) Pharmacokinetics of butorphanol tartrate in rabbits. Am J Vet Res 53:541-543
33. Smith MA, Picker MJ (1998) Tolerance and cross tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor. Psychopharmacology 140:57-68
34. Sosnowski M, Yaksh TL (1990) Differential cross tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology 73:1141-1147
35. Stevens CW, Yaksh TL (1989) Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 250:1-8
36. Suzuki T, Narita M, Misawa M, Nagase H (1991) Pentazocine-induced biphasic analgesia in mice. Life Sci 48:1827-1835
37. Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs. Springer, New York
38. Tiano MJ, Walker EA, Dykstra LA (1998) Cross-tolerance to etorphine differentiates mu-opioid agonists in a rat tail withdrawal assay. Analgesia 3:251-257
39. Walker EA, Butelman ER, DeCosta BR, Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267:280-286
40. White PF (1989) Current and future trends in acute pain management. Clin J Pain 5:51-58
41. Woods JH, Gmerek DE (1985) Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233-247
42. Woods JH, Young AM, Herling S (1982) Classification of narcotics on the bases of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Fed Proc 41:221-227
43. Woolfolk DR, Holtzman SG (1995) Rat strain differences in the potentiation of morphine-induced analgesia by stress. Pharmacol Biochem Behav 51:699-703
44. Yoburn BC, Sierra V, Lutfy K (1989) Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol 170:193-200
45. Young AM, Kapitsopoulos G, Makhay MM (1991) Tolerance to morphine-like stimulus effects of mu opioid agonists. J Pharmacol Exp Ther 257:795-805
46. Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261: 246-257
47. Yabaluri N, Medzihradsky F (1997) Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol Pharmacol 52:896-902
48. Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner IL, Sukin SR, Gintzler AR (1982) Naltrexone-induced opiate receptor super-sensitivity. Brain Res 245:285-292